ArticleBiotechnology letters2026
Assessment of glycanolytic enzymes producing potentialities of three strains of Penicillium sp.
Article in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Strains of Penicillium sp. are known to produce various enzymes with industrial relevance. The primary objective of the study is to determine the glycanolytic enzyme-producing potentialities of three Penicillium sp. strains, viz. PDF4, XDF1(i), and XDF7(iii), and to optimize the enzyme production and activity at different pH and temperatures. The efficacy of enzyme production and enzyme activities was tested both qualitatively and quantitatively using different glycan and lignocellulosic substrates under varying pH and temperature conditions. Among the strains, Penicillium oxalicum strain XDF7(iii) (ITS: OR555781; NL: OR555751) was the highest pectinase producer (0.303547 μmol mL
Indexed as
Identifiers
41528572What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.